Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?
Objective: To determine the recurrence rate and survival among early-stage epithelial ovarian cancer cases considering homologous recombination deficiency (HRD) status. Methods: Single institution retrospective study of stage I/II EOC patients from 2017 to 2020. HRD was defined as evidence of germli...
Main Authors: | Monica D. Levine, David M. O'Malley, Paulina J. Haight, Leigha Senter, Vincent Wagner, Kristin L. Bixel, David E. Cohn, Larry J. Copeland, Casey M. Cosgrove, Eric M. McLaughlin, Floor J. Backes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Gynecologic Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578923000425 |
Similar Items
-
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
by: Rachael N. Piver, et al.
Published: (2023-04-01) -
Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer
by: Courtney J. Riedinger, et al.
Published: (2023-04-01) -
Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case series
by: Corinne A. Calo, et al.
Published: (2023-04-01) -
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population
by: Paulina J Haight, et al.
Published: (2023-08-01) -
The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
by: Sarah M. H. Einerhand, et al.
Published: (2023-05-01)